Integration of cancer stemness and neoantigen load to predict responsiveness to anti-PD1/PDL1 therapy

Overview of attention for article published in Frontiers in Cell and Developmental Biology, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,117 followers.

Integration of cancer stemness and neoantigen load to predict responsiveness to anti-PD1/PDL1 therapy https://t.co/ZV6DIlmC7Q

05 Dec 2022

Reply Repost Favourite

New Research: Integration of cancer stemness and neoantigen load to predict responsiveness to anti-PD1/PDL1 therapy: Background: Anti-programmed cell death 1/programmed cell death ligand 1 (PD1/PDL1) therapy is an important part of… https://t.co/MsdBRkFroF

17 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.